Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 22489561)

1.

WNT2 locus is involved in genetic susceptibility of Peyronie's disease.

Dolmans GH, Werker PM, de Jong IJ, Nijman RJ; LifeLines Cohort Study, Wijmenga C, Ophoff RA.

J Sex Med. 2012 May;9(5):1430-4. doi: 10.1111/j.1743-6109.2012.02704.x. Epub 2012 Apr 10.

PMID:
22489561
2.

Wnt signaling and Dupuytren's disease.

Dolmans GH, Werker PM, Hennies HC, Furniss D, Festen EA, Franke L, Becker K, van der Vlies P, Wolffenbuttel BH, Tinschert S, Toliat MR, Nothnagel M, Franke A, Klopp N, Wichmann HE, N├╝rnberg P, Giele H, Ophoff RA, Wijmenga C; Dutch Dupuytren Study Group; German Dupuytren Study Group; LifeLines Cohort Study; BSSH-GODD Consortium.

N Engl J Med. 2011 Jul 28;365(4):307-17. doi: 10.1056/NEJMoa1101029. Epub 2011 Jul 6.

3.

Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.

Qian A, Meals RA, Rajfer J, Gonzalez-Cadavid NF.

Urology. 2004 Aug;64(2):399-404.

PMID:
15302515
4.

The association between Peyronie's and Dupuytren's disease.

Nugteren HM, Nijman JM, de Jong IJ, van Driel MF.

Int J Impot Res. 2011 Jul-Aug;23(4):142-5. doi: 10.1038/ijir.2011.18. Epub 2011 Jun 2.

PMID:
21633367
5.

Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.

Bayat A, Alansar A, Hajeer AH, Shah M, Watson JS, Stanley JK, Ferguson MW, Ollier WE.

J Hand Surg Br. 2002 Feb;27(1):47-9.

PMID:
11895345
6.

No association between polymorphisms of WNT2 and schizophrenia in a Korean population.

Kim HJ, Park JK, Kim SK, Kang SW, Kim JW, Park HK, Cho AR, Song JY, Chung JH.

BMC Med Genet. 2010 May 24;11:78. doi: 10.1186/1471-2350-11-78.

7.

Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.

Tan EK, Kwok HH, Tan LC, Zhao WT, Prakash KM, Au WL, Pavanni R, Ng YY, Satake W, Zhao Y, Toda T, Liu JJ.

Neurology. 2010 Aug 10;75(6):508-12. doi: 10.1212/WNL.0b013e3181eccfcd. Erratum in: Neurology. 2010 Oct 12;75(15):1399. Kwok, H-K [corrected to Kwok, H-H].

8.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

9.

High-resolution whole-genome association study of Parkinson disease.

Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, Pant PV, Frazer KA, Cox DR, Ballinger DG.

Am J Hum Genet. 2005 Nov;77(5):685-93. Epub 2005 Sep 9.

10.

Association between autism and variants in the wingless-type MMTV integration site family member 2 ( WNT2) gene.

Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, Jinde S, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N.

Int J Neuropsychopharmacol. 2010 May;13(4):443-9. doi: 10.1017/S1461145709990903. Epub 2009 Nov 9.

PMID:
19895723
11.

Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease.

Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE.

Br J Plast Surg. 2003 Jun;56(4):328-33.

PMID:
12873459
12.

Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease.

Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W, Hackstein H.

J Urol. 2003 Jan;169(1):369-72.

PMID:
12478192
13.

Association study of the CNS patterning genes and autism in Han Chinese in Taiwan.

Chien YL, Wu YY, Chiu YN, Liu SK, Tsai WC, Lin PI, Chen CH, Gau SS, Chien WH.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 1;35(6):1512-7. doi: 10.1016/j.pnpbp.2011.04.010. Epub 2011 May 5.

PMID:
21575668
14.

The genetics and immunology of Peyronie's disease.

Noss MB, Day NS, Christ GJ, Melman A.

Int J Impot Res. 2000 Oct;12 Suppl 4:S127-32.

PMID:
11035400
15.

Dupuytren diathesis and genetic risk.

Dolmans GH, de Bock GH, Werker PM.

J Hand Surg Am. 2012 Oct;37(10):2106-11. doi: 10.1016/j.jhsa.2012.07.017.

PMID:
23021175
16.

Genome-wide association scan of Dupuytren's disease.

Ojwang JO, Adrianto I, Gray-McGuire C, Nath SK, Sun C, Kaufman KM, Harley JB, Rayan GM.

J Hand Surg Am. 2010 Dec;35(12):2039-45. doi: 10.1016/j.jhsa.2010.08.008. Epub 2010 Oct 25.

17.

Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.

Pavone C, Napoli G, Caruana G, Alonge V, Usala M, Abbadessa D.

BJU Int. 2012 Jul;110(1):117-21. doi: 10.1111/j.1464-410X.2011.10733.x. Epub 2011 Dec 16.

PMID:
22176734
18.

A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease.

Rhoden EL, Riedner CE, Fuchs SC, Ribeiro EP, Halmenschlager G.

J Sex Med. 2010 Apr;7(4 Pt 1):1529-37. doi: 10.1111/j.1743-6109.2009.01584.x. Epub 2009 Nov 12. Erratum in: J Sex Med. 2010 Jun;7(6):2296. Fuchs, Sandra [corrected to Fuchs, Sandra C].

PMID:
19912489
19.

Genetic analysis in a Dutch study sample identifies more ulcerative colitis susceptibility loci and shows their additive role in disease risk.

Festen EA, Stokkers PC, van Diemen CC, van Bodegraven AA, Boezen HM, Crusius BJ, Hommes DW, van der Woude CJ, Balschun T, Verspaget HW, Schreiber S, de Jong DJ, Franke A, Dijkstra G, Wijmenga C, Weersma RK.

Am J Gastroenterol. 2010 Feb;105(2):395-402. doi: 10.1038/ajg.2009.576. Epub 2009 Oct 27. Erratum in: Am J Gastroenterol. 2010 Feb;105(2):479. van der Woude, Janneke C [corrected to van der Woude, C Janneke].

PMID:
19861958
20.

Microsatellite alterations and loss of heterozygosity in Peyronie's disease.

Perinchery G, El-Sakka AI, Angan A, Nakajima K, Dharia A, Tanaka Y, Lue TF, Dahiya R.

J Urol. 2000 Sep;164(3 Pt 1):842-6.

PMID:
10953165
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk